Search research articles
Contact Us
Filters
Showing results (11-20 of 47) with videos related to
Page
of 5
Sort By:
Journal of Clinical Psychopharmacology
|
November 6, 2019
Phosphodiesterase 10A Inhibitor Monotherapy Is Not an Effective Treatment of Acute Schizophrenia
David P Walling, Anindita Banerjee, Vikas Dawra, et al.
Psychopharmacology
|
April 20, 2010
Amelioration of ketamine-induced working memory deficits by dopamine D1 receptor agonists
Brooke M Roberts, Patricia A Seymour, Christopher J Schmidt, et al.
The Journal of Physiology
|
April 6, 2004
Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels
Marzia Martina, Yelena Gorfinkel, Samantha Halman, et al.
Neuropharmacology
|
February 4, 2014
Phosphodiesterase 10A inhibitor MP-10 effects in primates: comparison with risperidone and mechanistic implications
Subramaniam Uthayathas, Gunasingh J Masilamoni, Christopher L Shaffer, et al.
Journal of Clinical Psychopharmacology
|
June 18, 2019
A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia
Nicholas DeMartinis, Rene N Lopez, Eve H Pickering, et al.
Neuropharmacology
|
December 7, 2007
Behavioral characterization of mice deficient in the phosphodiesterase-10A (PDE10A) enzyme on a C57/Bl6N congenic background
Judith A Siuciak, Sheryl A McCarthy, Douglas S Chapin, et al.
Neuroreport
|
February 27, 2010
Glycine transporter inhibition reverses ketamine-induced working memory deficits
Brooke M Roberts, Christopher L Shaffer, Patricia A Seymour, et al.
Neuropharmacology
|
September 22, 2009
Alterations in gene regulation following inhibition of the striatum-enriched phosphodiesterase, PDE10A
Christine A Strick, Larry C James, Carol B Fox, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
June 21, 2011
Development and validation of a sample stabilization strategy and a UPLC-MS/MS method for the simultaneous quantitation of acetylcholine (ACh), histamine (HA), and its metabolites in rat cerebrospinal fluid (CSF)
Yanhua Zhang, F David Tingley, Elaine Tseng, et al.
Behavioural Brain Research
|
March 30, 2010
Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction
Brooke M Roberts, Daniel E Holden, Christopher L Shaffer, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 47) with videos related to
Sort By:
Page
of 5
Journal of Clinical Psychopharmacology
|
November 6, 2019
Phosphodiesterase 10A Inhibitor Monotherapy Is Not an Effective Treatment of Acute Schizophrenia
David P Walling, Anindita Banerjee, Vikas Dawra, et al.
Psychopharmacology
|
April 20, 2010
Amelioration of ketamine-induced working memory deficits by dopamine D1 receptor agonists
Brooke M Roberts, Patricia A Seymour, Christopher J Schmidt, et al.
The Journal of Physiology
|
April 6, 2004
Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels
Marzia Martina, Yelena Gorfinkel, Samantha Halman, et al.
Neuropharmacology
|
February 4, 2014
Phosphodiesterase 10A inhibitor MP-10 effects in primates: comparison with risperidone and mechanistic implications
Subramaniam Uthayathas, Gunasingh J Masilamoni, Christopher L Shaffer, et al.
Journal of Clinical Psychopharmacology
|
June 18, 2019
A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia
Nicholas DeMartinis, Rene N Lopez, Eve H Pickering, et al.
Neuropharmacology
|
December 7, 2007
Behavioral characterization of mice deficient in the phosphodiesterase-10A (PDE10A) enzyme on a C57/Bl6N congenic background
Judith A Siuciak, Sheryl A McCarthy, Douglas S Chapin, et al.
Neuroreport
|
February 27, 2010
Glycine transporter inhibition reverses ketamine-induced working memory deficits
Brooke M Roberts, Christopher L Shaffer, Patricia A Seymour, et al.
Neuropharmacology
|
September 22, 2009
Alterations in gene regulation following inhibition of the striatum-enriched phosphodiesterase, PDE10A
Christine A Strick, Larry C James, Carol B Fox, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
June 21, 2011
Development and validation of a sample stabilization strategy and a UPLC-MS/MS method for the simultaneous quantitation of acetylcholine (ACh), histamine (HA), and its metabolites in rat cerebrospinal fluid (CSF)
Yanhua Zhang, F David Tingley, Elaine Tseng, et al.
Behavioural Brain Research
|
March 30, 2010
Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction
Brooke M Roberts, Daniel E Holden, Christopher L Shaffer, et al.
Page
of 5